Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
4 Oct 2024
Haemorrhages More Common and Deadly in Patients With Cancer
A recent study has found that haemorrhages are far more frequent in cancer patients than previously believed, posing a serious threat to their prognosis and overall survival
2 Oct 2024
Hema Now: Episode 1: Bridging Medicine, Wellness, and Community – Part 1
This week’s episode discusses the effects of COVID-19 on patients with haematological conditions, and medical education globally.
2 Oct 2024
Residual Disease Dynamics and Prognosis in Multiple Myeloma
A UCSF study highlights the importance of MRD assessment and clonal diversity in predicting clinical outcomes for multiple myeloma patients
29 Sep 2024
Risk of Second Primary Malignancies After CAR-T Therapy
A study has raised awareness about the risk of second primary malignancies in patients treated with chimeric antigen receptor T-cell therapy for hematologic cancers
28 Sep 2024
From the Lab: Integrating Chemokines and Machine Learning in Primary Immune Thrombocytopenia
A new study has highlighted chemokines as potential biomarkers that could enhance the diagnosis and bleeding evaluation in patients with primary immune thrombocytopenia
26 Sep 2024
Sickle Cell Trait Linked to Higher Blood Clot Risk
A study has revealed an increased risk of venous thromboembolism in individuals with sickle cell trait compared to those without the trait.
23 Sep 2024
Highlights on Pierre Fabre EHA 2024 Symposium: Changing the face of EBV+ PTLD with allogeneic T-cell therapies
Watch here the key takeaways from this year’s European Hematology Association (EHA) symposium that focused on the Management…
20 Sep 2024
Impact of Low Radiation on Blood Cancer Rates
The latest update to the INWORKS study enhances the understanding of the link between low-dose ionising radiation and mortality from haematological malignancies
Loading posts...
« Previous
1
…
34
35
36
37
38
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View